Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006497
Filing Date
2015-08-06
Accepted
2015-08-06 17:11:38
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-10q_20150630.htm 10-Q 1402153
2 EX-10.1 ctic-ex101_334.htm EX-10.1 100425
3 EX-10.3 ctic-ex103_233.htm EX-10.3 12957
4 EX-15 ctic-ex15_8.htm EX-15 3565
5 EX-31.1 ctic-ex311_6.htm EX-31.1 11518
6 EX-31.2 ctic-ex312_9.htm EX-31.2 12490
7 EX-32 ctic-ex32_7.htm EX-32 13158
8 GRAPHIC g20150806204202314857.jpg GRAPHIC 52374
9 GRAPHIC g20150806204202283857.jpg GRAPHIC 5541
  Complete submission text file 0001564590-15-006497.txt   3772831

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ctic-20150630.xml EX-101.INS 452637
11 XBRL TAXONOMY EXTENSION SCHEMA ctic-20150630.xsd EX-101.SCH 25235
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20150630_cal.xml EX-101.CAL 41480
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20150630_def.xml EX-101.DEF 92322
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20150630_lab.xml EX-101.LAB 240869
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20150630_pre.xml EX-101.PRE 165037
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 151034129
SIC: 2834 Pharmaceutical Preparations